Protocols›Longevity & bioregulator›Longevity Foundations
← Protocols
Athlete / performance · uptakeCommunity · convergenceNo approved clinical use

Longevity Foundations

Stack: Epitalon · NAD/NMN · GHK-Cu — the baseline ageing stack
"The combination people reach for first when the goal is 'ageing' rather than a single fix — a pineal bioregulator, an NAD precursor and a copper repair tripeptide run together. Each part has some human data on its own; the three-as-a-stack has none. Convention, not proof."
GoalLongevity / cellular maintenance
Compounds3 · Epitalon · NAD/NMN · GHK-Cu
Humans exposed (est.)High — undocumented
StatusMHRA (UK): none is a licensed medicine — Epitalon & GHK-Cu sold as research material; NMN sold as a supplement (legal to buy) · FDA (US): NMN not a lawful dietary-supplement ingredient (2022 ruling); Epitalon & GHK-Cu not approved
In this stack — snapshot; tap through for the full molecule file
Provenance & evidence layers — of the combination, not the parts
Longevity / biohacker convention
Where / who
Longevity, anti-ageing and biohacker communities — the default "baseline ageing stack" people assemble before targeting anything specific.
Use status
All three are widely used; running them together is community convention, not a documented regimen.
Evidence it adds
Popularity / convention — not efficacy of the combination.
Basis: real-world uptake & convention — not trial data
Per-compound human data
NAD/NMN
Has the strongest individual base: multiple randomised human trials of oral NMN on NAD+ levels and metabolic markers — generally well-tolerated, with modest and contested functional effects.
GHK-Cu
Decades of human topical-cosmetic data (skin, wound, collagen). Systemic/injected longevity use is extrapolated from in-vitro and gene-expression work, not human anti-ageing trials.
Epitalon
Russian clinical literature (Khavinson group) reports longevity and telomere effects; small, mostly single-centre, rarely independently replicated to Western trial standards.
What it means
Some real human evidence on the parts — strongest for NMN, weakest for Epitalon. None of it tests the three together.
Basis: per-compound trials — see each molecule page
No approved clinical use
Clinical record
No country lists this combination — or any single part — as an approved longevity therapy.
Human trials
No completed human trial of the combination. Stack-level evidence is absent.
Basis required for a clinical-use tag: none found — absence shown, not hidden
Regulatory — read carefully
MHRA (UK)
None is a licensed medicine. Epitalon & GHK-Cu are sold as research material; NMN is sold legally as a food supplement.
FDA (US)
FDA ruled NMN is not a lawful dietary-supplement ingredient (2022). Epitalon & GHK-Cu are not approved drugs.
What it means
UK-legal-to-buy (NMN as supplement) is not the same as proven or quality-controlled.
Why it matters
No marketing authorisation = no pharmacovigilance; adverse events aren't formally tracked.
Basis: MHRA supplement framework · FDA NMN ruling (2022)
Why this combination

Epitalon, NAD/NMN and GHK-Cu are stacked because each targets a different ageing lever — pineal/telomere signalling, cellular NAD+ supply, and copper-dependent repair/collagen respectively — so the convention is "cover several mechanisms at once" rather than push one hard. That logic is mechanistic and plausible; it is not backed by any trial of the three run together. The strongest individual evidence sits with NMN; the weakest with Epitalon.

Members only · the actionable depth
See exactly how it's run
Doses, cycle structure and what to monitor are part of membership. The provenance, evidence and exposure above are always free.
Get TiQ1 · Free →
Free · just create an account
Cycle shape — how it's typically structured, not a schedule to follow
Loading
build up
Maintenance
hold / taper
Off
stop / reassess
Convention from community use, not a prescription.
What's worth monitoring

There is no validated marker set for this combination, but a longevity stack is one where baseline bloods are most worth having — metabolic panel, fasting glucose/HbA1c and lipids give NMN something to read against, and a clinician conversation matters before adding injected compounds (Epitalon, GHK-Cu) on top of a supplement. Limited combination safety data is a reason for more caution, not less. General information, not medical advice.

Combination evidence
Real-world uptake High

A default baseline stack in longevity and biohacker circles.

Best-supported part NMN

Randomised human trials on NAD+ and metabolic markers — modest, contested effects.

Combination efficacy None

No human trial tests Epitalon + NAD/NMN + GHK-Cu together.

The honest ceiling

Plausible mechanisms, some data on the parts, nothing on the whole. A reasonable baseline to read about — not a proven longevity intervention.

Fast facts
Compounds

Epitalon · NAD/NMN · GHK-Cu

Humans exposed (est.)

High — undocumented.

UK strip

GREEN — NMN supplement; Epitalon & GHK-Cu research material